Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma
Oral Diseases · 2025
DOI: 10.1111/odi.15075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Tong Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Frontier Innovation C…. Hauptthemen laut MEDLINE: Metformin, Drug Resistance, Neoplasm, Kruppel-Like Transcription Factors, Mouth Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Objective
Chemoresistance is a common event after chemotherapy, including oral squamous cell carcinoma (OSCC). Accumulated evidence suggests that the cancer stemness significantly contributes to therapy resistance. An unresolved question remains regarding how to effectively overcome OSCC chemoresistance by targeting stemness. This study aims to investigate the antitumor effect of metformin and clarify the potential molecular mechanisms.
Methods
Cellular models resistant to chemotherapy were established, and their viability and sphere‐forming ability were assessed using CCK‐8 and soft agar formation assays, respectively. RNA‐seq and Western blotting analyses were employed to delve into the molecular pathways. Furthermore, to corroborate the inhibitory effects of metformin and cisplatin at an animal level, a subcutaneous tumor transplantation model was instituted.
Results
Metformin as a monotherapy exhibited inhibition of stemness traits via Krüppel‐like factor 4 (KLF4). Metformin and cisplatin can synergically inhibit cell proliferation and induce cell apoptosis. Animal experiments confirmed the inhibitory effect of cisplatin and metformin on tumor in mice.
Conclusion
Our study proposes a potential therapeutic approach of combining chemotherapy with metformin to overcome chemoresistance in OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Frontier Innovation Center for Dental Medicine Plus & Research Unit of Oral Carcinogenesis…
- Key Laboratory of Oral Biomedical Research of Zhejiang Province, Affiliated Stomatology Hospital, Zhejiang University School of Stomatology, Hangzhou, Zhejiang, China.
- Department of Head and Neck Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology…
ORCID-Profile: Tong Zhou
Zitieren
APA
Zhou, T., Zhang, X., Yang, D., Wei, W., Gan, J., Xia, X., Chen, Q., Jiang, J., & Feng, X. (2025). Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma. Oral Diseases. https://doi.org/10.1111/odi.15075
Vancouver
Zhou T, Zhang X, Yang D, Wei W, Gan J, Xia X, et al. Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma. Oral Diseases. 2025. doi:10.1111/odi.15075
BibTeX
@article{Zhou2025,
author = {Zhou, Tong and Zhang, Xuefeng and Yang, Dan and Wei, Weideng and Gan, Jianguo and Xia, Xiaoqiang and Chen, Qianming and Jiang, Jian and Feng, Xiaodong},
title = {Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15075}
}
EUVIMED